Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 11,790 | 11,175 | 10,460 | 29,175 | 24,124 |
| Cost of Goods | N/A | N/A | N/A | 7,977 | 4,435 |
| Gross Profit | 11,790 | 11,175 | 10,460 | 21,198 | 19,689 |
| Operating Expenses | 43,462 | 47,405 | 54,995 | 7,827 | 54,469 |
| Operating Income | -31,672 | -36,230 | -44,535 | 14,348 | -34,345 |
| Interest Expense | 6,047 | 5,394 | 4,974 | 10,153 | 6,020 |
| Other Income | 2,164 | -157 | -1,321 | 2,807 | 3,317 |
| Pre-tax Income | -35,555 | -41,781 | -50,830 | 7,002 | -37,048 |
| Income Tax | -33 | -188 | 52 | -259 | 9 |
| Net Income Continuous | -35,522 | -41,593 | -50,882 | 7,261 | -37,057 |
| Net Income | $-35,522 | $-41,593 | $-50,882 | $7,261 | $-37,057 |
| EPS Basic Total Ops | -1.87 | -2.95 | -3.60 | 0.57 | -2.66 |
| EPS Basic Continuous Ops | -1.87 | -2.95 | -3.62 | 0.58 | -2.66 |
| EPS Diluted Total Ops | -1.87 | -2.95 | -3.60 | 0.57 | -2.66 |
| EPS Diluted Continuous Ops | -1.87 | -2.95 | -3.62 | 0.58 | -2.66 |
| EPS Diluted Before Non-Recurring Items | -1.85 | -2.95 | -3.30 | -2.25 | -2.70 |
| EBITDA(a) | $-32,909 | $-36,885 | $-45,433 | $22,391 | $-35,416 |